Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-08-20
2011-10-25
Anderson, James (Department: 1629)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
08044093
ABSTRACT:
A pharmaceutical composition of docetaxel comprising an effective amount of docetaxel, a polysorbate (TWEEN® compound) and a co-solvent, wherein the co-solvent is at least one member selected from the group consisting of glycerol and polyethylene glycol. The composition is an injectable solution or a freeze-dried powder for injection. The solubility of decetaxel is improved by adding a polysorbate and a co-solvent. Methods of preparation of the pharmaceutical composition are also disclosed.
REFERENCES:
patent: 5698582 (1997-12-01), Bastart et al.
patent: 6251428 (2001-06-01), Yoo
patent: 6388112 (2002-05-01), Anevski
patent: 6828346 (2004-12-01), Joshi-Hangal et al.
patent: 2003/0077297 (2003-04-01), Chen et al.
patent: 2003/0207936 (2003-11-01), Chen
patent: WO 97/23208 (1997-07-01), None
patent: WO 2006/133510 (2006-12-01), None
Chen et al. Pharmaceutical Research, Aug. 2003, vol. 20, No. 8, pp. 1302-1308.
Anderson James
Beijing Century Biocom Pharmaceutical Technology Co., Ltd.
Matthias Scholl P.C.
Scholl Matthias
LandOfFree
Pharmaceutical compositions comprising docetaxel and methods... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions comprising docetaxel and methods..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions comprising docetaxel and methods... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4273957